Monitoring, removal and risk assessment of cytostatic drugs in hospital wastewater.

Cytostatic agents are applied in cancer therapy and subsequently excreted into hospital wastewater. As these substances are known to be carcinogenic, mutagenic and toxic for reproduction, they should be removed from wastewater at their source of origin. In this study the fate and effects of the cancerostatic platinum compounds (CPC) cisplatin, carboplatin, oxaliplatin, 5-fluorouracil (5-FU) and the anthracyclines doxorubicin, daunorubicin and epirubicin were investigated in hospital wastewater. Wastewater from the in-patient treatment ward of a hospital in Vienna was collected and monitored for the occurrence of the selected drugs. A calculation model was established to spot the correlation between administered dosage and measured concentrations. To investigate the fate of the selected substances during wastewater treatment, the oncologic wastewater was treated in a pilot membrane bioreactor system (MBR) and in downstream advanced wastewater treatment processes (adsorption to activated carbon and UV-treatment). Genotoxic effects of the oncologic wastewater were assessed before and after wastewater treatment followed by a risk assessment. Monitoring concentrations of the selected cytostatics in the oncologic wastewater were in line with calculated concentrations. Due to different mechanisms (adsorption, biodegradation) in the MBR-system 5 - FU and the anthracyclines were removed < LOD, whereas CPC were removed by 60%. In parallel, genotoxic effects could be reduced significantly by the MBR-system. The risk for humans, the aquatic and terrestrial environment by hospital wastewater containing cytostatic drugs was classified as small in a preliminary risk assessment.

[1]  M. Fuerhacker,et al.  Fate of cancerostatic platinum compounds in biological wastewater treatment of hospital effluents. , 2007, Chemosphere.

[2]  M. Fuerhacker,et al.  Benzalkonium chloride (BAC) and dimethyldioctadecyl-ammonium bromide (DDAB), two common quaternary ammonium compounds, cause genotoxic effects in mammalian and plant cells at environmentally relevant concentrations. , 2007, Mutagenesis.

[3]  M. Fuerhacker,et al.  Development of an analytical method for the determination of anthracyclines in hospital effluents. , 2006, Chemosphere.

[4]  G. Stingeder,et al.  Presence of cancerostatic platinum compounds in hospital wastewater and possible elimination by adsorption to activated sludge. , 2005, The Science of the total environment.

[5]  M. Fuerhacker,et al.  Determination of 5-fluorouracil in hospital effluents , 2004, Analytical and bioanalytical chemistry.

[6]  W. Buchberger,et al.  Application of HPLC-ICP-MS to speciation of cisplatin and its degradation products in water containing different chloride concentrations and in human urine , 2003 .

[7]  H. Dunkelberg,et al.  Genotoxicity of platinum and palladium compounds in human and bacterial cells. , 1997, Mutation research.

[8]  B. Ames,et al.  Revised methods for the Salmonella mutagenicity test. , 1983, Mutation research.

[9]  R M Mader,et al.  Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane-bio-reactor system. , 2007, Chemosphere.

[10]  G. Stingeder,et al.  Novel separation method for highly sensitive speciation of cancerostatic platinum compounds by HPLC–ICP–MS , 2005, Analytical and bioanalytical chemistry.